Correction Factor for Protein Binding [Bioanalytics]

posted by vamshi – 2008-08-14 13:29 (6527 d 13:41 ago) – Posting: # 2183
Views: 4,487

Hari,

For Bioequivalence study of the formulation, you need to Compare the Test and reference (innovator) product.

You can refer orange book and OGD (office of generic drugs of FDA).

Even if your formulation Bioequivalence/ NCE you need prove Recovery in method validation is satisfactory.

As your Calibration standards, Quality Controls and study sample, reference study samples will be processed under same conditions.

You may consider same values for Statistics.

Not required to calculate free and bound form.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
370 visitors (0 registered, 370 guests [including 20 identified bots]).
Forum time: 03:11 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5